SCHEMBL2773472

SCHEMBL2773472

Cc1ccc(OC(C[O])c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.52
SLC6A4 P31645 9/20 0.49
HTR1A P08908 1/20 0.46
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SLC6A2 P23975 3/20 0.42
SLC6A3 Q01959 3/20 0.42
HRH3 Q9Y5N1 2/20 0.42
NPC1 O15118 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
MTOR P42345 2/20 0.42
RAB9A P51151 2/20 0.42
KCNK2 O95069 2/20 0.42
KCNH2 Q12809 2/20 0.42
CACNA1C Q13936 2/20 0.42
LMNA P02545 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28368709 0.87 SLC6A4 (0.55) SLC6A4MEN1KMT2ASLC6A2SLC6A3
SCHEMBL10021745 0.84 IGLV6-57 (0.51) SLC6A9SLC6A4HTR1AMEN1KMT2A
SCHEMBL3976067 0.82 SLC6A9 (0.52) SLC6A9SLC6A4HTR1APPARGPPARA
SCHEMBL1582685 0.81 SLC6A9 (0.56) SLC6A9SLC6A4HTR1APPARGPPARA
SCHEMBL13042191 0.81 SLC6A9 (0.54) SLC6A9SLC6A4HTR1AMEN1KMT2A
SCHEMBL14063965 0.80 SLC6A9 (0.54) SLC6A9SLC6A4HTR1APPARGPPARA
SCHEMBL6007168 0.79 SLC6A4 (0.54) SLC6A9SLC6A4HTR1AMEN1KMT2A
SCHEMBL684955 0.79 SLC6A4 (0.66) SLC6A9SLC6A4HTR1ASLC6A2SLC6A3
SCHEMBL5533459 0.78 SLC7A5 (0.55) SLC6A9SLC6A4HTR1AMEN1KMT2A
SCHEMBL5533205 0.78 SLC6A9 (0.46) SLC6A9SLC6A4HTR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563508-A2 DELIVERY PARTICLE The Procter & Gamble Company (US) 2013-03-06 EP claimed
WO-2010079468-A2 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2010-07-15 WO claimed
EP-3956054-A1 METHODS OF MAKING CAPSULES The Procter & Gamble Company (US) 2022-02-23 EP disclosed
WO-2020214878-A1 METHODS OF MAKING CAPSULES THE PROCTER & GAMBLE COMPANY (US) 2020-10-22 WO disclosed
EP-2563508-A2 DELIVERY PARTICLE The Procter & Gamble Company (US) 2013-03-06 EP disclosed
EP-2563894-A2 DELIVERY PARTICLES The Procter & Gamble Company (US) 2013-03-06 EP disclosed
EP-2563896-A2 DELIVERY PARTICLES The Procter & Gamble Company (US) 2013-03-06 EP disclosed
EP-2563507-A2 DELIVERY PARTICLES The Procter & Gamble Company (US) 2013-03-06 EP disclosed
WO-2010084480-A2 DELIVERY PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2010-07-29 WO disclosed
WO-2010079466-A2 DELIVERY PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2010-07-15 WO disclosed
WO-2010079468-A2 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2010-07-15 WO disclosed
WO-2010079467-A2 DELIVERY PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2010-07-15 WO disclosed